Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,779 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomised, placebo-controlled trial and meta-analysis show benefit of ondansetron for irritable bowel syndrome with diarrhoea: The TRITON trial.
Gunn D, Topan R, Barnard L, Fried R, Holloway I, Brindle R, Corsetti M, Scott M, Farmer A, Kapur K, Sanders D, Eugenicos M, Trudgill N, Whorwell P, Mclaughlin J, Akbar A, Houghton L, Dinning PG, Aziz Q, Ford AC, Farrin AJ, Spiller R. Gunn D, et al. Among authors: mclaughlin j. Aliment Pharmacol Ther. 2023 Jun;57(11):1258-1271. doi: 10.1111/apt.17426. Epub 2023 Mar 3. Aliment Pharmacol Ther. 2023. PMID: 36866724 Free article.
UK clinical experience up to 52 weeks with linaclotide for irritable bowel syndrome with constipation.
Yiannakou Y, Agrawal A, Allen PB, Arebi N, Brown SR, Eugenicos MP, Farmer AD, McLain-Smith S, McLaughlin J, Sanders DS, Lawrance D, Emmanuel A. Yiannakou Y, et al. Among authors: mclaughlin j. Therap Adv Gastroenterol. 2018 Oct 3;11:1756284818798791. doi: 10.1177/1756284818798791. eCollection 2018. Therap Adv Gastroenterol. 2018. PMID: 30302125 Free PMC article.
Treatment of irritable bowel syndrome with diarrhoea using titrated ondansetron (TRITON): study protocol for a randomised controlled trial.
Gunn D, Fried R, Lalani R, Farrin A, Holloway I, Morris T, Olivier C, Kearns R, Corsetti M, Scott M, Farmer A, Emmanuel A, Whorwell P, Yiannakou Y, Sanders D, Mclaughlin J, Kapur K, Eugenicos M, Akbar A, Trudgill N, Houghton L, Dinning PG, Ford AC, Aziz Q, Spiller R. Gunn D, et al. Among authors: mclaughlin j. Trials. 2019 Aug 20;20(1):517. doi: 10.1186/s13063-019-3562-6. Trials. 2019. PMID: 31429811 Free PMC article.
Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adults.
Kemppinen A, Howell C, Allgar V, Dodd M, Gregson J, Knowles C, McLaughlin J, Pandya P, Whorwell P, Markaryan E, Yiannakou Y. Kemppinen A, et al. Among authors: mclaughlin j. Trials. 2020 Jan 30;21(1):122. doi: 10.1186/s13063-020-4069-x. Trials. 2020. PMID: 32000822 Free PMC article.
Commentary: a comparison of glucagon-like peptides 1 and 2.
Moran GW, Lal S, McLaughlin JT. Moran GW, et al. Among authors: mclaughlin jt. Aliment Pharmacol Ther. 2013 Jan;37(2):279-80. doi: 10.1111/apt.12165. Aliment Pharmacol Ther. 2013. PMID: 23252781 Free article. No abstract available.
Attitudes to out-of-programme experiences, research and academic training of gastroenterology trainees between 2007 and 2016.
McFarlane M, Bhala N, China L, Alrubaiy L, Chedgy F, Disney BR, Farmer AD, Fogden E, Sadler G, Hull MA, McLaughlin J, Ellison H, Solomon J, Brookes MJ. McFarlane M, et al. Among authors: mclaughlin j. Frontline Gastroenterol. 2019 Jan;10(1):57-66. doi: 10.1136/flgastro-2018-100993. Epub 2018 Jun 19. Frontline Gastroenterol. 2019. PMID: 30651959 Free PMC article.
2,779 results